Intervention study by pharmacy pharmacist to prevent flail
Not Applicable
- Conditions
- Flail
- Registration Number
- JPRN-UMIN000042571
- Lead Sponsor
- General Incorporated Association Osaka Pharmaplan Aozora Pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are undergoing treatment that may affect physical malnutrition or bones, such as cancer patients. Patients who are prescribed an osteoporosis drug. Patients who are prescribed antidepressants or antipsychotics. Patients who are prescribed steroids. Patients who are prescribed dementia medication. Obese patients with a BMI of 30% or higher. Patients receiving exercise restriction guidance from their doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of change(Kg) and the rate of change(%) of "muscle mass by site" measured with a body composition analyzer after 6 months. The rate of change(%) after 6 months of the "5 times chair stand-up test".
- Secondary Outcome Measures
Name Time Method The amount and rate of change of "body weight," "body fat percentage," "BMI," and "estimated bone mass" measured with a body composition analyzer after 6 months. Comparison between groups of the results of the "health status questionnaire" that was first surveyed and comparison of the amount of change in body composition. Evaluation of the results of the "retrospective questionnaire" surveyed 6 months later.